Position in KRYS
as of Jun 30, 2026
· filed Aug 6, 2026
Position Value
$530,001
+$204,260 QoQ
Shares Held
1,426
+13.1% QoQ
Ownership
0.005%
of shares outstanding
% of Portfolio
0.02%
of 13F equity value
Holder Rank
#237
of 419 holders
Holding Since
Sep 2024
7 quarters on record
Voting authority
Sole 31%
Shared 0%
None 69%
Common Shares in KRYS Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026Argent Trust Co holds $4,756,008 across 11 Biotechnology names. KRYS ranks #3 (11.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | REGN |
Regeneron Pharmaceuticals, Inc.
|
1,749 | $1,090,571 | |
| 2 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
2,014 | $1,000,412 | |
| 3 | KRYS |
Krystal Biotech, Inc.
This page
|
1,426 | $530,001 | |
| 4 | LGND |
Ligand Pharmaceuticals Inc
|
1,220 | $385,629 | |
| 5 | TGTX |
Tg Therapeutics, Inc.
|
5,598 | $307,553 | |
| 6 | AXSM |
Axsome Therapeutics, Inc.
|
1,174 | $287,359 | |
| 7 | IONS |
Ionis Pharmaceuticals Inc
|
3,018 | $239,296 | |
| 8 | CORT |
Corcept Therapeutics Inc
|
2,679 | $232,938 |
All Filings in KRYS
Export CSV
7 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $530,001 | 1,426 | Shares | Sole | 2026-08-06 | |
| 2026-03-31 | $325,741 | 1,261 | Shares | Sole | 2026-05-13 | |
| 2025-12-31 | $310,886 | 1,261 | Shares | Sole | 2026-02-10 | |
| 2025-09-30 | $230,724 | 1,307 | Shares | Sole | 2025-11-12 | |
| 2025-03-31 | $305,067 | 1,692 | Shares | Defined | 2025-05-09 | |
| 2024-12-31 | $297,497 | 1,899 | Shares | Defined | 2025-02-13 | |
| 2024-09-30 | $345,674 | 1,899 | Shares | Defined | 2024-11-13 | |
| No filing history on record for this holder in this stock. | ||||||